Cyclacel Pharmaceuticals (CYCC)
(Delayed Data from NSDQ)
$2.31 USD
-0.01 (-0.43%)
Updated May 9, 2024 04:00 PM ET
After-Market: $2.30 -0.01 (-0.43%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: AMC |
3/2024 | $-4.93 | 0.00% |
Earnings Summary
For their last quarter, Cyclacel Pharmaceuticals (CYCC) reported earnings of -$6.23 per share, beating the Zacks Consensus Estimate of $-6.35 per share. This reflects a positive earnings surprise of 1.89%. Look out for CYCC's next earnings release on May 14, 2024. For the next earning release, we expect the company to report earnings of -$4.93 per share, reflecting a year-over-year increase of 30.07%.
Earnings History
Price & Consensus
Zacks News for CYCC
Cyclacel Pharmaceuticals, Inc. (CYCC) Upgraded to Strong Buy: Here's Why
CYCC: What are Zacks experts saying now?
Zacks Private Portfolio Services